NDC 0409-7335-13 - Ceftriaxone Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-7335
- Requested NDC
- 0409-7335-13
- Package NDCs from labels
- 0409-7335-13, 0409-7335-03, 0409-7335-21, 0409-7335-20
- Manufacturer
- Hospira, Inc
- Effective date
- 2026-01-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ceftriaxone Sodium - Hospira, Inc | Hospira, Inc | 2026-01-19 | HUMAN PRESCRIPTION DRUG LABEL |
| Ceftriaxone Sodium - Hospira, Inc | Hospira, Inc | 2026-01-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-7335-03 | Ceftriaxone Sodium | 10 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 10 | 21 | |
| 0409-7335-13 | Ceftriaxone Sodium | 1 in 1 VIAL, SINGLE-USE | INJECTION, POWDER, FOR SOLUTION | 1 | 21 | |
| 0409-7335-20 | Ceftriaxone Sodium | 10 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 10 | 5 | |
| 0409-7335-21 | Ceftriaxone Sodium | 1 in 1 VIAL, SINGLE-USE | INJECTION, POWDER, FOR SOLUTION | 1 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0409-7335 | CEFTRIAXONE SODIUM INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC] | 20 | Current NDC, Legacy NDC, 2 package rows | 20240113_03283208-8616-4117-9d2b-aa8046017a4f.zip |
| 0409-7335 | CEFTRIAXONE SODIUM INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC] | 4 | Current NDC, Legacy NDC, 2 package rows | 20240113_19141ccd-e66c-49a2-a794-0616028495a7.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-7335-03 | EA - Each | 0409-7335 | f94d4e3a-894b-48c2-a3dc-0f0682da0fa7 | 1 | 2012-07-24 |
| 0409-7335-13 | EA - Each | 0409-7335 | 41c1fc4c-cd54-4ee4-85c6-3b0e99967753 | 1 | 2018-08-13 |
| 0409-7335-20 | EA - Each | 0409-7335 | b86e8c21-ea7f-4051-bafc-0a147c31bf40 | 1 | 2018-05-09 |
| 0409-7335-61 | EA - Each | 0409-7335 | f24ff174-c46c-490e-95c4-75e79353509d | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CEFTRIAXONE SODIUM | ACTIVE INGREDIENT | 023Z5BR09K | CEFTRIAXONE SODIUM INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC] | 16 | |
| CEFTRIAXONE | ACTIVE MOIETY | 75J73V1629 | CEFTRIAXONE SODIUM INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC] | 16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | A-S Medication Solutions | 1aa0a4ee-1b39-4c3d-a7a3-33dded6fe28c | 2024-01-31 | Warnings, Adverse reactions | ANDA065169 309092 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | A-S Medication Solutions | ff8e830a-c288-46fb-9e19-ec2017943c07 | 2024-01-31 | Warnings, Adverse reactions | ANDA065169 309092 023Z5BR09K |
| ceftriaxone | CEFTRIAXONE | Sagent Pharmaceuticals | 5cf93bc5-9e4c-4734-bc02-c7d0ac071022 | 2023-11-08 | Warnings, Adverse reactions | 1665046 1665005 1665021 023Z5BR09K |
| Ceftriaxone | CEFTRIAXONE | Fresenius Kabi USA, LLC | 7ea1db43-40fa-417b-8911-ae98092070a0 | 2023-09-30 | Warnings, Adverse reactions | 1665046 1665005 1665021 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Asclemed USA, Inc. | f01cf0e5-caaf-4759-ba21-50f3aceff523 | 2023-09-02 | Warnings, Adverse reactions | 1665005 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Apotex Corp. | 5116231f-82d1-44be-b08e-560c9a50e5c5 | 2023-08-31 | Warnings, Adverse reactions | 1665046 1665005 309092 1665021 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Apotex Corp. | ac03a72c-0e35-40f9-b7fc-081badb5f19c | 2023-01-28 | Warnings, Adverse reactions | 023Z5BR09K |
| Ceftriaxone | CEFTRIAXONE SODIUM | Samson Medical Technologies, LLC | 5cd2d96f-83e5-4326-ae87-d0ede4ba493a | 2023-01-15 | Warnings, Adverse reactions | 023Z5BR09K |
| Ceftriaxone | CEFTRIAXONE | Proficient Rx LP | fcf401df-bcdc-4773-a63b-9741c0f74b3d | 2022-11-01 | Warnings, Adverse reactions | 1665046 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Proficient Rx LP | a25ab5ea-c46d-4562-8f7e-0ccffc2ab069 | 2022-10-01 | Warnings, Adverse reactions | ANDA065169 1665046 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Proficient Rx LP | 42ba7a9d-7d2b-4eac-af59-897151a8c924 | 2022-05-02 | Warnings, Adverse reactions | 1665021 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Hospira, Inc | 9d1f630b-e759-4395-9d01-ddc90e4fea75 | 2022-03-09 | Warnings, Adverse reactions | 1665046 1665021 023Z5BR09K |
| CEFTRIAXONE AND DEXTROSE | CEFTRIAXONE | B. Braun Medical Inc. | 67153914-16bc-490d-82d7-638061618467 | 2022-01-13 | Warnings, Adverse reactions | 1665046 1665021 023Z5BR09K |
| Ceftriaxone | CEFTRIAXONE | Hikma Pharmaceuticals USA Inc. | 1f8776bd-4f5b-427a-849a-6b8338f7997d | 2019-04-24 | Warnings, Adverse reactions | 023Z5BR09K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.